Rituximab for managing relapsing or refractory patients with idiopathic thrombotic thrombocytopenic purpura--haemolytic uraemic syndrome.
Caramazza
Domenica
D
Cattedra ed U.O. di Ematologia con trapianto, Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone di Palermo Via del Vespro 127, I-90127 Palermo, Italy.
Quintini
Gerlando
G
Abbene
Ignazio
I
Coco
Lucio Lo
LL
Malato
Alessandra
A
Di Trapani
Rosa
R
Saccullo
Giorgia
G
Pizzo
Giuseppina
G
Palazzolo
Roberto
R
Barone
Rita
R
Mazzola
Giuseppina
G
Rizzo
Sergio
S
Ragonese
Paolo
P
Aridon
Paolo
P
Abbadessa
Vincenzo
V
Siragusa
Sergio
S
D051722:ADAM Proteins / Q000097:blood; D000071120:ADAMTS13 Protein; D000293:Adolescent; D000328:Adult; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D011697:Purpura, Thrombotic Thrombocytopenic / Q000188:drug therapy; D000069283:Rituximab; D016879:Salvage Therapy / Q000379:methods; D016896:Treatment Outcome
D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D000069283:Rituximab; D051722:ADAM Proteins; D000071120:ADAMTS13 Protein; C099604:ADAMTS13 protein, human